Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Gastrointestinal Stromal Tumors 1Erectile Dysfunction 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × 4-Aminopyridine × 1 year × Clear all
NCT07171203 2026-05-27

Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

University of California, San Diego

Phase 1 Recruiting
18 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03701581 2025-12-17

4-aminopyridine Treatment for Nerve Injury

University of Arizona

Phase 2/3 Recruiting
70 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡